Protocols
Myeloablative conditioning therapy prior to autologous and allogeneic hematopoietic stem cell transplantation for myeloid malignancies using IV busulfan and cyclophosphamide
Pre-Emptive riTUXimab Therapy of Epstein-Barr Virus (EBV) Related Post-Transplant Lymphoproliferative Disease
Conditioning therapy for autologous stem cell transplant using high dose melphalan in the treatment of multiple myeloma
Single dose cyclophosphamide priming therapy for multiple myeloma prior to autologous stem cell transplant.
Maintenance Oral azaCITIDine for Acute Myeloid Leukemia
Therapy of Acute Myeloid Leukemia Using azaCITIDine and SORAfenib
Therapy of Acute Myeloid Leukemia using azaCITIDine and Venetoclax
Therapy of Acute Myeloid Leukemia Using Low dose Cytarabine
Therapy of Acute Myeloid Leukemia using DAUNOrubicin Liposomal-Cytarabine Liposomal
Therapy of Relapsed or Refractory FLT3+ Acute Myeloid Leukemia using Gilteritinib
Therapy of FLT3+ Acute Myeloid Leukemia Using Midostaurin in Combination with Induction and Consolidation Chemotherapy
Anagrelide as second-line treatment of thrombocytosis related to myeloproliferative disorders
First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid)
First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide, Tretinoin (All-Trans Retinoic Acid) and DAUNOrubicin
Induction and Consolidation Therapy of Relapsed Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid)
Treatment of Philadelphia Chromosome (Ph)-Positive or Ph-Negative Refractory or Relapsed PreB-Cell Acute Lymphoblastic Leukemia with Blinatumomab
Treatment
of Chronic Myeloid Leukemia Using Bosutinib
Therapy for Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Imatinib
Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Dasatinib
Treatment of Chronic Myeloid Leukemia Using Nilotinib
Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Ponatinib
Treatment of Acute Myeloid Leukemia Using Gemtuzumab Ozogamicin with Induction and Consolidation Chemotherapy
Treatment of Relapsed or Refractory Pre-B Cell Acute Lymphoblastic Leukemia with Inotuzumab Ozogamicin
Therapy of Myelodysplastic Syndrome using Azacitidine
Therapy of Myelodysplastic Syndrome using Decitabine-Cedazuridine
Therapy of Myelodysplastic Syndrome using Lenalidomide
Treatment of Symptomatic Myelofibrosis with Fedratinib
Treatment of Symptomatic Myelofibrosis with Ruxolitinib
Treatment of Pre-B-Cell Acute Lymphoblastic Leukemia with Minimal Residual Disease using Blinatumomab
Treatment of Polycythemia Vera with Ruxolitinib
Peginterferon Alfa-2a Therapy of Chronic Myeloid Neoplasms and Hypereosinophilic Syndrome
Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, vinCRIstine, DOXOrubicin, Methotrexate, Leucovorin (CODOX-M) and riTUXimab
Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and riTUXimab
